INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=1211388, encodeId=f9f71211388c0, content=偏重的研究方向：生物信息学;肿瘤 经验分享：投的纯生信。不过分析比较复杂，不是烂大街的套路文。第四天模板拒。个人总结原因 1：创新性或临床转化意义可能不够 2：没实验 3：中国医院？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4e8b5460993, createdName=ms1000001833329884, createdTime=Fri Apr 15 11:16:21 CST 2022, time=2022-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1054925, encodeId=02161054925d4, content=我的WB上下剪胶了，不是整张膜，提供原始数据时只提交三个带marker的条带行吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=fa185487321, createdName=明心2021, createdTime=Sun Sep 26 10:45:41 CST 2021, time=2021-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2118273, encodeId=2f2421182e3bf, content=想问一下大家，这个期刊提交手稿的时候，是必须按他们的word template吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cbc85726390, createdName=Y-Liv, createdTime=Wed Mar 08 13:53:00 CST 2023, time=2023-03-08, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2118485, encodeId=5414211848561, content=偏重的研究方向：分子生物学 经验分享：想问下这个杂志处了需要WB和荧光图的原始数据，其他计算类的还需要整理吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6dc08112186, createdName=ms3000001011350398, createdTime=Thu Mar 09 13:33:22 CST 2023, time=2023-03-09, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2206064, encodeId=0e7c2206064f1, content=偏重的研究方向：肝脏疾病;肿瘤 经验分享：现在pending的时间是变长了吗，看到23年的基本都是隔天送审，我已经pending4天了慌张。。。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74479171808, createdName=ms4000001066891631, createdTime=Wed May 22 18:36:10 CST 2024, time=2024-05-22, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2211109, encodeId=890422111096d, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：综合期刊;生命科学;医学综合 经验分享：2023年度影响因子为4.9分，还是相当不错的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/Random/55971dc507c93968175ce7cc1e177b372a83869f.jpg, createdBy=f63e4754896, createdName=侠胆医心, createdTime=Sat Jun 22 05:58:26 CST 2024, time=2024-06-22, status=1, ipAttribution=威斯康星), GetPortalCommentsPageByObjectIdResponse(id=2205292, encodeId=34342205292a0, content=请问免疫荧光的图也要未裁剪前的当原始数据吗？还有WB原始数据只要有对应的膜就行了吗，不是一定要全膜，且还要三次重复吧？IHC的图需要全片扫描的吗，还是特定展示区域的图就行？毕业在即，恳求解惑呀，各位大佬。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=89068352819, createdName=ms7000001215694189, createdTime=Fri May 17 21:53:58 CST 2024, time=2024-05-17, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2201848, encodeId=b39422018487d, content=偏重的研究方向：分子生物 经验分享：2023.12.20 22:00 Pending review 2023.12.21 16:00 Under review 2024.1.5 12:30 Pending major revise 2024.1.10 11:30 Resubmitted 2024.1.10 12:00 Requirements satisfied 2024.1.10 14:00 Pending review 2024.1.10 14:00 Revised version review 2024.1.11 16:00 Pending decision 2024.1.11 16:00 Pending editor decision 2024.1.13 15:00 Paper accepted 2024.1.13 15:00 Pending English 2024.1.14 English correction done 2024.1.14 16:30 Author poofreading 2024.1.14 22:30 Author poofreading-resubmitted 2024.1.15 13:00 Final check 2024.1.15 13:00 Pending conversation 2024.1.17 17:00 xml2pdf done 2023.1.17 17:30 pending online-website online, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7bb81967620, createdName=于陌上, createdTime=Sun May 05 17:17:49 CST 2024, time=2024-05-05, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2198932, encodeId=4a532198932bc, content=3天了没反应, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=125, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d40e6504141, createdName=ms8000002033126213, createdTime=Wed Apr 17 11:27:52 CST 2024, time=2024-04-17, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2197816, encodeId=3b6f219e816e6, content=同医院秒拒没给原因, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8a8a9166627, createdName=ms6000002076658983, createdTime=Wed Apr 10 20:43:04 CST 2024, time=2024-04-10, status=1, ipAttribution=北京)]

2022-04-15 ms1000001833329884

偏重的研究方向：生物信息学;肿瘤
经验分享：投的纯生信。不过分析比较复杂，不是烂大街的套路文。第四天模板拒。个人总结原因 1：创新性或临床转化意义可能不够 2：没实验 3：中国医院？

69 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=1211388, encodeId=f9f71211388c0, content=偏重的研究方向：生物信息学;肿瘤 经验分享：投的纯生信。不过分析比较复杂，不是烂大街的套路文。第四天模板拒。个人总结原因 1：创新性或临床转化意义可能不够 2：没实验 3：中国医院？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4e8b5460993, createdName=ms1000001833329884, createdTime=Fri Apr 15 11:16:21 CST 2022, time=2022-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1054925, encodeId=02161054925d4, content=我的WB上下剪胶了，不是整张膜，提供原始数据时只提交三个带marker的条带行吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=fa185487321, createdName=明心2021, createdTime=Sun Sep 26 10:45:41 CST 2021, time=2021-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2118273, encodeId=2f2421182e3bf, content=想问一下大家，这个期刊提交手稿的时候，是必须按他们的word template吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cbc85726390, createdName=Y-Liv, createdTime=Wed Mar 08 13:53:00 CST 2023, time=2023-03-08, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2118485, encodeId=5414211848561, content=偏重的研究方向：分子生物学 经验分享：想问下这个杂志处了需要WB和荧光图的原始数据，其他计算类的还需要整理吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6dc08112186, createdName=ms3000001011350398, createdTime=Thu Mar 09 13:33:22 CST 2023, time=2023-03-09, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2206064, encodeId=0e7c2206064f1, content=偏重的研究方向：肝脏疾病;肿瘤 经验分享：现在pending的时间是变长了吗，看到23年的基本都是隔天送审，我已经pending4天了慌张。。。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74479171808, createdName=ms4000001066891631, createdTime=Wed May 22 18:36:10 CST 2024, time=2024-05-22, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2211109, encodeId=890422111096d, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：综合期刊;生命科学;医学综合 经验分享：2023年度影响因子为4.9分，还是相当不错的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/Random/55971dc507c93968175ce7cc1e177b372a83869f.jpg, createdBy=f63e4754896, createdName=侠胆医心, createdTime=Sat Jun 22 05:58:26 CST 2024, time=2024-06-22, status=1, ipAttribution=威斯康星), GetPortalCommentsPageByObjectIdResponse(id=2205292, encodeId=34342205292a0, content=请问免疫荧光的图也要未裁剪前的当原始数据吗？还有WB原始数据只要有对应的膜就行了吗，不是一定要全膜，且还要三次重复吧？IHC的图需要全片扫描的吗，还是特定展示区域的图就行？毕业在即，恳求解惑呀，各位大佬。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=89068352819, createdName=ms7000001215694189, createdTime=Fri May 17 21:53:58 CST 2024, time=2024-05-17, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2201848, encodeId=b39422018487d, content=偏重的研究方向：分子生物 经验分享：2023.12.20 22:00 Pending review 2023.12.21 16:00 Under review 2024.1.5 12:30 Pending major revise 2024.1.10 11:30 Resubmitted 2024.1.10 12:00 Requirements satisfied 2024.1.10 14:00 Pending review 2024.1.10 14:00 Revised version review 2024.1.11 16:00 Pending decision 2024.1.11 16:00 Pending editor decision 2024.1.13 15:00 Paper accepted 2024.1.13 15:00 Pending English 2024.1.14 English correction done 2024.1.14 16:30 Author poofreading 2024.1.14 22:30 Author poofreading-resubmitted 2024.1.15 13:00 Final check 2024.1.15 13:00 Pending conversation 2024.1.17 17:00 xml2pdf done 2023.1.17 17:30 pending online-website online, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7bb81967620, createdName=于陌上, createdTime=Sun May 05 17:17:49 CST 2024, time=2024-05-05, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2198932, encodeId=4a532198932bc, content=3天了没反应, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=125, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d40e6504141, createdName=ms8000002033126213, createdTime=Wed Apr 17 11:27:52 CST 2024, time=2024-04-17, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2197816, encodeId=3b6f219e816e6, content=同医院秒拒没给原因, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8a8a9166627, createdName=ms6000002076658983, createdTime=Wed Apr 10 20:43:04 CST 2024, time=2024-04-10, status=1, ipAttribution=北京)]

2021-09-26 明心2021

我的WB上下剪胶了，不是整张膜，提供原始数据时只提交三个带marker的条带行吗？

109 11

展开11条回复

[GetPortalCommentsPageByObjectIdResponse(id=1211388, encodeId=f9f71211388c0, content=偏重的研究方向：生物信息学;肿瘤 经验分享：投的纯生信。不过分析比较复杂，不是烂大街的套路文。第四天模板拒。个人总结原因 1：创新性或临床转化意义可能不够 2：没实验 3：中国医院？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4e8b5460993, createdName=ms1000001833329884, createdTime=Fri Apr 15 11:16:21 CST 2022, time=2022-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1054925, encodeId=02161054925d4, content=我的WB上下剪胶了，不是整张膜，提供原始数据时只提交三个带marker的条带行吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=fa185487321, createdName=明心2021, createdTime=Sun Sep 26 10:45:41 CST 2021, time=2021-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2118273, encodeId=2f2421182e3bf, content=想问一下大家，这个期刊提交手稿的时候，是必须按他们的word template吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cbc85726390, createdName=Y-Liv, createdTime=Wed Mar 08 13:53:00 CST 2023, time=2023-03-08, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2118485, encodeId=5414211848561, content=偏重的研究方向：分子生物学 经验分享：想问下这个杂志处了需要WB和荧光图的原始数据，其他计算类的还需要整理吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6dc08112186, createdName=ms3000001011350398, createdTime=Thu Mar 09 13:33:22 CST 2023, time=2023-03-09, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2206064, encodeId=0e7c2206064f1, content=偏重的研究方向：肝脏疾病;肿瘤 经验分享：现在pending的时间是变长了吗，看到23年的基本都是隔天送审，我已经pending4天了慌张。。。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74479171808, createdName=ms4000001066891631, createdTime=Wed May 22 18:36:10 CST 2024, time=2024-05-22, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2211109, encodeId=890422111096d, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：综合期刊;生命科学;医学综合 经验分享：2023年度影响因子为4.9分，还是相当不错的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/Random/55971dc507c93968175ce7cc1e177b372a83869f.jpg, createdBy=f63e4754896, createdName=侠胆医心, createdTime=Sat Jun 22 05:58:26 CST 2024, time=2024-06-22, status=1, ipAttribution=威斯康星), GetPortalCommentsPageByObjectIdResponse(id=2205292, encodeId=34342205292a0, content=请问免疫荧光的图也要未裁剪前的当原始数据吗？还有WB原始数据只要有对应的膜就行了吗，不是一定要全膜，且还要三次重复吧？IHC的图需要全片扫描的吗，还是特定展示区域的图就行？毕业在即，恳求解惑呀，各位大佬。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=89068352819, createdName=ms7000001215694189, createdTime=Fri May 17 21:53:58 CST 2024, time=2024-05-17, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2201848, encodeId=b39422018487d, content=偏重的研究方向：分子生物 经验分享：2023.12.20 22:00 Pending review 2023.12.21 16:00 Under review 2024.1.5 12:30 Pending major revise 2024.1.10 11:30 Resubmitted 2024.1.10 12:00 Requirements satisfied 2024.1.10 14:00 Pending review 2024.1.10 14:00 Revised version review 2024.1.11 16:00 Pending decision 2024.1.11 16:00 Pending editor decision 2024.1.13 15:00 Paper accepted 2024.1.13 15:00 Pending English 2024.1.14 English correction done 2024.1.14 16:30 Author poofreading 2024.1.14 22:30 Author poofreading-resubmitted 2024.1.15 13:00 Final check 2024.1.15 13:00 Pending conversation 2024.1.17 17:00 xml2pdf done 2023.1.17 17:30 pending online-website online, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7bb81967620, createdName=于陌上, createdTime=Sun May 05 17:17:49 CST 2024, time=2024-05-05, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2198932, encodeId=4a532198932bc, content=3天了没反应, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=125, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d40e6504141, createdName=ms8000002033126213, createdTime=Wed Apr 17 11:27:52 CST 2024, time=2024-04-17, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2197816, encodeId=3b6f219e816e6, content=同医院秒拒没给原因, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8a8a9166627, createdName=ms6000002076658983, createdTime=Wed Apr 10 20:43:04 CST 2024, time=2024-04-10, status=1, ipAttribution=北京)]

2023-03-08 Y-Liv 来自辽宁省

想问一下大家，这个期刊提交手稿的时候，是必须按他们的word template吗

46 4

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=1211388, encodeId=f9f71211388c0, content=偏重的研究方向：生物信息学;肿瘤 经验分享：投的纯生信。不过分析比较复杂，不是烂大街的套路文。第四天模板拒。个人总结原因 1：创新性或临床转化意义可能不够 2：没实验 3：中国医院？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4e8b5460993, createdName=ms1000001833329884, createdTime=Fri Apr 15 11:16:21 CST 2022, time=2022-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1054925, encodeId=02161054925d4, content=我的WB上下剪胶了，不是整张膜，提供原始数据时只提交三个带marker的条带行吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=fa185487321, createdName=明心2021, createdTime=Sun Sep 26 10:45:41 CST 2021, time=2021-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2118273, encodeId=2f2421182e3bf, content=想问一下大家，这个期刊提交手稿的时候，是必须按他们的word template吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cbc85726390, createdName=Y-Liv, createdTime=Wed Mar 08 13:53:00 CST 2023, time=2023-03-08, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2118485, encodeId=5414211848561, content=偏重的研究方向：分子生物学 经验分享：想问下这个杂志处了需要WB和荧光图的原始数据，其他计算类的还需要整理吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6dc08112186, createdName=ms3000001011350398, createdTime=Thu Mar 09 13:33:22 CST 2023, time=2023-03-09, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2206064, encodeId=0e7c2206064f1, content=偏重的研究方向：肝脏疾病;肿瘤 经验分享：现在pending的时间是变长了吗，看到23年的基本都是隔天送审，我已经pending4天了慌张。。。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74479171808, createdName=ms4000001066891631, createdTime=Wed May 22 18:36:10 CST 2024, time=2024-05-22, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2211109, encodeId=890422111096d, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：综合期刊;生命科学;医学综合 经验分享：2023年度影响因子为4.9分，还是相当不错的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/Random/55971dc507c93968175ce7cc1e177b372a83869f.jpg, createdBy=f63e4754896, createdName=侠胆医心, createdTime=Sat Jun 22 05:58:26 CST 2024, time=2024-06-22, status=1, ipAttribution=威斯康星), GetPortalCommentsPageByObjectIdResponse(id=2205292, encodeId=34342205292a0, content=请问免疫荧光的图也要未裁剪前的当原始数据吗？还有WB原始数据只要有对应的膜就行了吗，不是一定要全膜，且还要三次重复吧？IHC的图需要全片扫描的吗，还是特定展示区域的图就行？毕业在即，恳求解惑呀，各位大佬。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=89068352819, createdName=ms7000001215694189, createdTime=Fri May 17 21:53:58 CST 2024, time=2024-05-17, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2201848, encodeId=b39422018487d, content=偏重的研究方向：分子生物 经验分享：2023.12.20 22:00 Pending review 2023.12.21 16:00 Under review 2024.1.5 12:30 Pending major revise 2024.1.10 11:30 Resubmitted 2024.1.10 12:00 Requirements satisfied 2024.1.10 14:00 Pending review 2024.1.10 14:00 Revised version review 2024.1.11 16:00 Pending decision 2024.1.11 16:00 Pending editor decision 2024.1.13 15:00 Paper accepted 2024.1.13 15:00 Pending English 2024.1.14 English correction done 2024.1.14 16:30 Author poofreading 2024.1.14 22:30 Author poofreading-resubmitted 2024.1.15 13:00 Final check 2024.1.15 13:00 Pending conversation 2024.1.17 17:00 xml2pdf done 2023.1.17 17:30 pending online-website online, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7bb81967620, createdName=于陌上, createdTime=Sun May 05 17:17:49 CST 2024, time=2024-05-05, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2198932, encodeId=4a532198932bc, content=3天了没反应, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=125, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d40e6504141, createdName=ms8000002033126213, createdTime=Wed Apr 17 11:27:52 CST 2024, time=2024-04-17, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2197816, encodeId=3b6f219e816e6, content=同医院秒拒没给原因, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8a8a9166627, createdName=ms6000002076658983, createdTime=Wed Apr 10 20:43:04 CST 2024, time=2024-04-10, status=1, ipAttribution=北京)]

2023-03-09 ms3000001011350398 来自上海

偏重的研究方向：分子生物学
经验分享：想问下这个杂志处了需要WB和荧光图的原始数据，其他计算类的还需要整理吗

0 8

展开8条回复

[GetPortalCommentsPageByObjectIdResponse(id=1211388, encodeId=f9f71211388c0, content=偏重的研究方向：生物信息学;肿瘤 经验分享：投的纯生信。不过分析比较复杂，不是烂大街的套路文。第四天模板拒。个人总结原因 1：创新性或临床转化意义可能不够 2：没实验 3：中国医院？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4e8b5460993, createdName=ms1000001833329884, createdTime=Fri Apr 15 11:16:21 CST 2022, time=2022-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1054925, encodeId=02161054925d4, content=我的WB上下剪胶了，不是整张膜，提供原始数据时只提交三个带marker的条带行吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=fa185487321, createdName=明心2021, createdTime=Sun Sep 26 10:45:41 CST 2021, time=2021-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2118273, encodeId=2f2421182e3bf, content=想问一下大家，这个期刊提交手稿的时候，是必须按他们的word template吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cbc85726390, createdName=Y-Liv, createdTime=Wed Mar 08 13:53:00 CST 2023, time=2023-03-08, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2118485, encodeId=5414211848561, content=偏重的研究方向：分子生物学 经验分享：想问下这个杂志处了需要WB和荧光图的原始数据，其他计算类的还需要整理吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6dc08112186, createdName=ms3000001011350398, createdTime=Thu Mar 09 13:33:22 CST 2023, time=2023-03-09, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2206064, encodeId=0e7c2206064f1, content=偏重的研究方向：肝脏疾病;肿瘤 经验分享：现在pending的时间是变长了吗，看到23年的基本都是隔天送审，我已经pending4天了慌张。。。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74479171808, createdName=ms4000001066891631, createdTime=Wed May 22 18:36:10 CST 2024, time=2024-05-22, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2211109, encodeId=890422111096d, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：综合期刊;生命科学;医学综合 经验分享：2023年度影响因子为4.9分，还是相当不错的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/Random/55971dc507c93968175ce7cc1e177b372a83869f.jpg, createdBy=f63e4754896, createdName=侠胆医心, createdTime=Sat Jun 22 05:58:26 CST 2024, time=2024-06-22, status=1, ipAttribution=威斯康星), GetPortalCommentsPageByObjectIdResponse(id=2205292, encodeId=34342205292a0, content=请问免疫荧光的图也要未裁剪前的当原始数据吗？还有WB原始数据只要有对应的膜就行了吗，不是一定要全膜，且还要三次重复吧？IHC的图需要全片扫描的吗，还是特定展示区域的图就行？毕业在即，恳求解惑呀，各位大佬。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=89068352819, createdName=ms7000001215694189, createdTime=Fri May 17 21:53:58 CST 2024, time=2024-05-17, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2201848, encodeId=b39422018487d, content=偏重的研究方向：分子生物 经验分享：2023.12.20 22:00 Pending review 2023.12.21 16:00 Under review 2024.1.5 12:30 Pending major revise 2024.1.10 11:30 Resubmitted 2024.1.10 12:00 Requirements satisfied 2024.1.10 14:00 Pending review 2024.1.10 14:00 Revised version review 2024.1.11 16:00 Pending decision 2024.1.11 16:00 Pending editor decision 2024.1.13 15:00 Paper accepted 2024.1.13 15:00 Pending English 2024.1.14 English correction done 2024.1.14 16:30 Author poofreading 2024.1.14 22:30 Author poofreading-resubmitted 2024.1.15 13:00 Final check 2024.1.15 13:00 Pending conversation 2024.1.17 17:00 xml2pdf done 2023.1.17 17:30 pending online-website online, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7bb81967620, createdName=于陌上, createdTime=Sun May 05 17:17:49 CST 2024, time=2024-05-05, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2198932, encodeId=4a532198932bc, content=3天了没反应, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=125, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d40e6504141, createdName=ms8000002033126213, createdTime=Wed Apr 17 11:27:52 CST 2024, time=2024-04-17, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2197816, encodeId=3b6f219e816e6, content=同医院秒拒没给原因, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8a8a9166627, createdName=ms6000002076658983, createdTime=Wed Apr 10 20:43:04 CST 2024, time=2024-04-10, status=1, ipAttribution=北京)]

2024-05-22 ms4000001066891631 来自江西省

偏重的研究方向：肝脏疾病;肿瘤
经验分享：现在pending的时间是变长了吗，看到23年的基本都是隔天送审，我已经pending4天了慌张。。。。。

89 5

展开5条回复

[GetPortalCommentsPageByObjectIdResponse(id=1211388, encodeId=f9f71211388c0, content=偏重的研究方向：生物信息学;肿瘤 经验分享：投的纯生信。不过分析比较复杂，不是烂大街的套路文。第四天模板拒。个人总结原因 1：创新性或临床转化意义可能不够 2：没实验 3：中国医院？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4e8b5460993, createdName=ms1000001833329884, createdTime=Fri Apr 15 11:16:21 CST 2022, time=2022-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1054925, encodeId=02161054925d4, content=我的WB上下剪胶了，不是整张膜，提供原始数据时只提交三个带marker的条带行吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=fa185487321, createdName=明心2021, createdTime=Sun Sep 26 10:45:41 CST 2021, time=2021-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2118273, encodeId=2f2421182e3bf, content=想问一下大家，这个期刊提交手稿的时候，是必须按他们的word template吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cbc85726390, createdName=Y-Liv, createdTime=Wed Mar 08 13:53:00 CST 2023, time=2023-03-08, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2118485, encodeId=5414211848561, content=偏重的研究方向：分子生物学 经验分享：想问下这个杂志处了需要WB和荧光图的原始数据，其他计算类的还需要整理吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6dc08112186, createdName=ms3000001011350398, createdTime=Thu Mar 09 13:33:22 CST 2023, time=2023-03-09, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2206064, encodeId=0e7c2206064f1, content=偏重的研究方向：肝脏疾病;肿瘤 经验分享：现在pending的时间是变长了吗，看到23年的基本都是隔天送审，我已经pending4天了慌张。。。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74479171808, createdName=ms4000001066891631, createdTime=Wed May 22 18:36:10 CST 2024, time=2024-05-22, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2211109, encodeId=890422111096d, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：综合期刊;生命科学;医学综合 经验分享：2023年度影响因子为4.9分，还是相当不错的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/Random/55971dc507c93968175ce7cc1e177b372a83869f.jpg, createdBy=f63e4754896, createdName=侠胆医心, createdTime=Sat Jun 22 05:58:26 CST 2024, time=2024-06-22, status=1, ipAttribution=威斯康星), GetPortalCommentsPageByObjectIdResponse(id=2205292, encodeId=34342205292a0, content=请问免疫荧光的图也要未裁剪前的当原始数据吗？还有WB原始数据只要有对应的膜就行了吗，不是一定要全膜，且还要三次重复吧？IHC的图需要全片扫描的吗，还是特定展示区域的图就行？毕业在即，恳求解惑呀，各位大佬。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=89068352819, createdName=ms7000001215694189, createdTime=Fri May 17 21:53:58 CST 2024, time=2024-05-17, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2201848, encodeId=b39422018487d, content=偏重的研究方向：分子生物 经验分享：2023.12.20 22:00 Pending review 2023.12.21 16:00 Under review 2024.1.5 12:30 Pending major revise 2024.1.10 11:30 Resubmitted 2024.1.10 12:00 Requirements satisfied 2024.1.10 14:00 Pending review 2024.1.10 14:00 Revised version review 2024.1.11 16:00 Pending decision 2024.1.11 16:00 Pending editor decision 2024.1.13 15:00 Paper accepted 2024.1.13 15:00 Pending English 2024.1.14 English correction done 2024.1.14 16:30 Author poofreading 2024.1.14 22:30 Author poofreading-resubmitted 2024.1.15 13:00 Final check 2024.1.15 13:00 Pending conversation 2024.1.17 17:00 xml2pdf done 2023.1.17 17:30 pending online-website online, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7bb81967620, createdName=于陌上, createdTime=Sun May 05 17:17:49 CST 2024, time=2024-05-05, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2198932, encodeId=4a532198932bc, content=3天了没反应, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=125, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d40e6504141, createdName=ms8000002033126213, createdTime=Wed Apr 17 11:27:52 CST 2024, time=2024-04-17, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2197816, encodeId=3b6f219e816e6, content=同医院秒拒没给原因, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8a8a9166627, createdName=ms6000002076658983, createdTime=Wed Apr 10 20:43:04 CST 2024, time=2024-04-10, status=1, ipAttribution=北京)]

2024-06-22 侠胆医心来自威斯康星

审稿速度:3.0 | 投稿命中率:75.0
偏重的研究方向：综合期刊;生命科学;医学综合
经验分享：2023年度影响因子为4.9分，还是相当不错的

88 0

[GetPortalCommentsPageByObjectIdResponse(id=1211388, encodeId=f9f71211388c0, content=偏重的研究方向：生物信息学;肿瘤 经验分享：投的纯生信。不过分析比较复杂，不是烂大街的套路文。第四天模板拒。个人总结原因 1：创新性或临床转化意义可能不够 2：没实验 3：中国医院？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4e8b5460993, createdName=ms1000001833329884, createdTime=Fri Apr 15 11:16:21 CST 2022, time=2022-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1054925, encodeId=02161054925d4, content=我的WB上下剪胶了，不是整张膜，提供原始数据时只提交三个带marker的条带行吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=fa185487321, createdName=明心2021, createdTime=Sun Sep 26 10:45:41 CST 2021, time=2021-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2118273, encodeId=2f2421182e3bf, content=想问一下大家，这个期刊提交手稿的时候，是必须按他们的word template吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cbc85726390, createdName=Y-Liv, createdTime=Wed Mar 08 13:53:00 CST 2023, time=2023-03-08, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2118485, encodeId=5414211848561, content=偏重的研究方向：分子生物学 经验分享：想问下这个杂志处了需要WB和荧光图的原始数据，其他计算类的还需要整理吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6dc08112186, createdName=ms3000001011350398, createdTime=Thu Mar 09 13:33:22 CST 2023, time=2023-03-09, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2206064, encodeId=0e7c2206064f1, content=偏重的研究方向：肝脏疾病;肿瘤 经验分享：现在pending的时间是变长了吗，看到23年的基本都是隔天送审，我已经pending4天了慌张。。。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74479171808, createdName=ms4000001066891631, createdTime=Wed May 22 18:36:10 CST 2024, time=2024-05-22, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2211109, encodeId=890422111096d, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：综合期刊;生命科学;医学综合 经验分享：2023年度影响因子为4.9分，还是相当不错的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/Random/55971dc507c93968175ce7cc1e177b372a83869f.jpg, createdBy=f63e4754896, createdName=侠胆医心, createdTime=Sat Jun 22 05:58:26 CST 2024, time=2024-06-22, status=1, ipAttribution=威斯康星), GetPortalCommentsPageByObjectIdResponse(id=2205292, encodeId=34342205292a0, content=请问免疫荧光的图也要未裁剪前的当原始数据吗？还有WB原始数据只要有对应的膜就行了吗，不是一定要全膜，且还要三次重复吧？IHC的图需要全片扫描的吗，还是特定展示区域的图就行？毕业在即，恳求解惑呀，各位大佬。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=89068352819, createdName=ms7000001215694189, createdTime=Fri May 17 21:53:58 CST 2024, time=2024-05-17, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2201848, encodeId=b39422018487d, content=偏重的研究方向：分子生物 经验分享：2023.12.20 22:00 Pending review 2023.12.21 16:00 Under review 2024.1.5 12:30 Pending major revise 2024.1.10 11:30 Resubmitted 2024.1.10 12:00 Requirements satisfied 2024.1.10 14:00 Pending review 2024.1.10 14:00 Revised version review 2024.1.11 16:00 Pending decision 2024.1.11 16:00 Pending editor decision 2024.1.13 15:00 Paper accepted 2024.1.13 15:00 Pending English 2024.1.14 English correction done 2024.1.14 16:30 Author poofreading 2024.1.14 22:30 Author poofreading-resubmitted 2024.1.15 13:00 Final check 2024.1.15 13:00 Pending conversation 2024.1.17 17:00 xml2pdf done 2023.1.17 17:30 pending online-website online, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7bb81967620, createdName=于陌上, createdTime=Sun May 05 17:17:49 CST 2024, time=2024-05-05, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2198932, encodeId=4a532198932bc, content=3天了没反应, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=125, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d40e6504141, createdName=ms8000002033126213, createdTime=Wed Apr 17 11:27:52 CST 2024, time=2024-04-17, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2197816, encodeId=3b6f219e816e6, content=同医院秒拒没给原因, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8a8a9166627, createdName=ms6000002076658983, createdTime=Wed Apr 10 20:43:04 CST 2024, time=2024-04-10, status=1, ipAttribution=北京)]

2024-05-17 ms7000001215694189 来自上海

请问免疫荧光的图也要未裁剪前的当原始数据吗？还有WB原始数据只要有对应的膜就行了吗，不是一定要全膜，且还要三次重复吧？IHC的图需要全片扫描的吗，还是特定展示区域的图就行？毕业在即，恳求解惑呀，各位大佬。

91 0

[GetPortalCommentsPageByObjectIdResponse(id=1211388, encodeId=f9f71211388c0, content=偏重的研究方向：生物信息学;肿瘤 经验分享：投的纯生信。不过分析比较复杂，不是烂大街的套路文。第四天模板拒。个人总结原因 1：创新性或临床转化意义可能不够 2：没实验 3：中国医院？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4e8b5460993, createdName=ms1000001833329884, createdTime=Fri Apr 15 11:16:21 CST 2022, time=2022-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1054925, encodeId=02161054925d4, content=我的WB上下剪胶了，不是整张膜，提供原始数据时只提交三个带marker的条带行吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=fa185487321, createdName=明心2021, createdTime=Sun Sep 26 10:45:41 CST 2021, time=2021-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2118273, encodeId=2f2421182e3bf, content=想问一下大家，这个期刊提交手稿的时候，是必须按他们的word template吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cbc85726390, createdName=Y-Liv, createdTime=Wed Mar 08 13:53:00 CST 2023, time=2023-03-08, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2118485, encodeId=5414211848561, content=偏重的研究方向：分子生物学 经验分享：想问下这个杂志处了需要WB和荧光图的原始数据，其他计算类的还需要整理吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6dc08112186, createdName=ms3000001011350398, createdTime=Thu Mar 09 13:33:22 CST 2023, time=2023-03-09, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2206064, encodeId=0e7c2206064f1, content=偏重的研究方向：肝脏疾病;肿瘤 经验分享：现在pending的时间是变长了吗，看到23年的基本都是隔天送审，我已经pending4天了慌张。。。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74479171808, createdName=ms4000001066891631, createdTime=Wed May 22 18:36:10 CST 2024, time=2024-05-22, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2211109, encodeId=890422111096d, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：综合期刊;生命科学;医学综合 经验分享：2023年度影响因子为4.9分，还是相当不错的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/Random/55971dc507c93968175ce7cc1e177b372a83869f.jpg, createdBy=f63e4754896, createdName=侠胆医心, createdTime=Sat Jun 22 05:58:26 CST 2024, time=2024-06-22, status=1, ipAttribution=威斯康星), GetPortalCommentsPageByObjectIdResponse(id=2205292, encodeId=34342205292a0, content=请问免疫荧光的图也要未裁剪前的当原始数据吗？还有WB原始数据只要有对应的膜就行了吗，不是一定要全膜，且还要三次重复吧？IHC的图需要全片扫描的吗，还是特定展示区域的图就行？毕业在即，恳求解惑呀，各位大佬。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=89068352819, createdName=ms7000001215694189, createdTime=Fri May 17 21:53:58 CST 2024, time=2024-05-17, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2201848, encodeId=b39422018487d, content=偏重的研究方向：分子生物 经验分享：2023.12.20 22:00 Pending review 2023.12.21 16:00 Under review 2024.1.5 12:30 Pending major revise 2024.1.10 11:30 Resubmitted 2024.1.10 12:00 Requirements satisfied 2024.1.10 14:00 Pending review 2024.1.10 14:00 Revised version review 2024.1.11 16:00 Pending decision 2024.1.11 16:00 Pending editor decision 2024.1.13 15:00 Paper accepted 2024.1.13 15:00 Pending English 2024.1.14 English correction done 2024.1.14 16:30 Author poofreading 2024.1.14 22:30 Author poofreading-resubmitted 2024.1.15 13:00 Final check 2024.1.15 13:00 Pending conversation 2024.1.17 17:00 xml2pdf done 2023.1.17 17:30 pending online-website online, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7bb81967620, createdName=于陌上, createdTime=Sun May 05 17:17:49 CST 2024, time=2024-05-05, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2198932, encodeId=4a532198932bc, content=3天了没反应, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=125, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d40e6504141, createdName=ms8000002033126213, createdTime=Wed Apr 17 11:27:52 CST 2024, time=2024-04-17, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2197816, encodeId=3b6f219e816e6, content=同医院秒拒没给原因, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8a8a9166627, createdName=ms6000002076658983, createdTime=Wed Apr 10 20:43:04 CST 2024, time=2024-04-10, status=1, ipAttribution=北京)]

2024-05-05 于陌上来自上海

偏重的研究方向：分子生物
经验分享：2023.12.20 22:00 Pending review 2023.12.21 16:00 Under review 2024.1.5 12:30 Pending major revise 2024.1.10 11:30 Resubmitted 2024.1.10 12:00 Requirements satisfied 2024.1.10 14:00 Pending review 2024.1.10 14:00 Revised version review 2024.1.11 16:00 Pending decision 2024.1.11 16:00 Pending editor decision 2024.1.13 15:00 Paper accepted 2024.1.13 15:00 Pending English 2024.1.14 English correction done 2024.1.14 16:30 Author poofreading 2024.1.14 22:30 Author poofreading-resubmitted 2024.1.15 13:00 Final check 2024.1.15 13:00 Pending conversation 2024.1.17 17:00 xml2pdf done 2023.1.17 17:30 pending online-website online

107 0

[GetPortalCommentsPageByObjectIdResponse(id=1211388, encodeId=f9f71211388c0, content=偏重的研究方向：生物信息学;肿瘤 经验分享：投的纯生信。不过分析比较复杂，不是烂大街的套路文。第四天模板拒。个人总结原因 1：创新性或临床转化意义可能不够 2：没实验 3：中国医院？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4e8b5460993, createdName=ms1000001833329884, createdTime=Fri Apr 15 11:16:21 CST 2022, time=2022-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1054925, encodeId=02161054925d4, content=我的WB上下剪胶了，不是整张膜，提供原始数据时只提交三个带marker的条带行吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=fa185487321, createdName=明心2021, createdTime=Sun Sep 26 10:45:41 CST 2021, time=2021-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2118273, encodeId=2f2421182e3bf, content=想问一下大家，这个期刊提交手稿的时候，是必须按他们的word template吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cbc85726390, createdName=Y-Liv, createdTime=Wed Mar 08 13:53:00 CST 2023, time=2023-03-08, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2118485, encodeId=5414211848561, content=偏重的研究方向：分子生物学 经验分享：想问下这个杂志处了需要WB和荧光图的原始数据，其他计算类的还需要整理吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6dc08112186, createdName=ms3000001011350398, createdTime=Thu Mar 09 13:33:22 CST 2023, time=2023-03-09, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2206064, encodeId=0e7c2206064f1, content=偏重的研究方向：肝脏疾病;肿瘤 经验分享：现在pending的时间是变长了吗，看到23年的基本都是隔天送审，我已经pending4天了慌张。。。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74479171808, createdName=ms4000001066891631, createdTime=Wed May 22 18:36:10 CST 2024, time=2024-05-22, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2211109, encodeId=890422111096d, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：综合期刊;生命科学;医学综合 经验分享：2023年度影响因子为4.9分，还是相当不错的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/Random/55971dc507c93968175ce7cc1e177b372a83869f.jpg, createdBy=f63e4754896, createdName=侠胆医心, createdTime=Sat Jun 22 05:58:26 CST 2024, time=2024-06-22, status=1, ipAttribution=威斯康星), GetPortalCommentsPageByObjectIdResponse(id=2205292, encodeId=34342205292a0, content=请问免疫荧光的图也要未裁剪前的当原始数据吗？还有WB原始数据只要有对应的膜就行了吗，不是一定要全膜，且还要三次重复吧？IHC的图需要全片扫描的吗，还是特定展示区域的图就行？毕业在即，恳求解惑呀，各位大佬。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=89068352819, createdName=ms7000001215694189, createdTime=Fri May 17 21:53:58 CST 2024, time=2024-05-17, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2201848, encodeId=b39422018487d, content=偏重的研究方向：分子生物 经验分享：2023.12.20 22:00 Pending review 2023.12.21 16:00 Under review 2024.1.5 12:30 Pending major revise 2024.1.10 11:30 Resubmitted 2024.1.10 12:00 Requirements satisfied 2024.1.10 14:00 Pending review 2024.1.10 14:00 Revised version review 2024.1.11 16:00 Pending decision 2024.1.11 16:00 Pending editor decision 2024.1.13 15:00 Paper accepted 2024.1.13 15:00 Pending English 2024.1.14 English correction done 2024.1.14 16:30 Author poofreading 2024.1.14 22:30 Author poofreading-resubmitted 2024.1.15 13:00 Final check 2024.1.15 13:00 Pending conversation 2024.1.17 17:00 xml2pdf done 2023.1.17 17:30 pending online-website online, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7bb81967620, createdName=于陌上, createdTime=Sun May 05 17:17:49 CST 2024, time=2024-05-05, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2198932, encodeId=4a532198932bc, content=3天了没反应, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=125, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d40e6504141, createdName=ms8000002033126213, createdTime=Wed Apr 17 11:27:52 CST 2024, time=2024-04-17, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2197816, encodeId=3b6f219e816e6, content=同医院秒拒没给原因, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8a8a9166627, createdName=ms6000002076658983, createdTime=Wed Apr 10 20:43:04 CST 2024, time=2024-04-10, status=1, ipAttribution=北京)]

2024-04-17 ms8000002033126213 来自浙江省

3天了没反应

125 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=1211388, encodeId=f9f71211388c0, content=偏重的研究方向：生物信息学;肿瘤 经验分享：投的纯生信。不过分析比较复杂，不是烂大街的套路文。第四天模板拒。个人总结原因 1：创新性或临床转化意义可能不够 2：没实验 3：中国医院？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4e8b5460993, createdName=ms1000001833329884, createdTime=Fri Apr 15 11:16:21 CST 2022, time=2022-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1054925, encodeId=02161054925d4, content=我的WB上下剪胶了，不是整张膜，提供原始数据时只提交三个带marker的条带行吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=fa185487321, createdName=明心2021, createdTime=Sun Sep 26 10:45:41 CST 2021, time=2021-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2118273, encodeId=2f2421182e3bf, content=想问一下大家，这个期刊提交手稿的时候，是必须按他们的word template吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cbc85726390, createdName=Y-Liv, createdTime=Wed Mar 08 13:53:00 CST 2023, time=2023-03-08, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2118485, encodeId=5414211848561, content=偏重的研究方向：分子生物学 经验分享：想问下这个杂志处了需要WB和荧光图的原始数据，其他计算类的还需要整理吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6dc08112186, createdName=ms3000001011350398, createdTime=Thu Mar 09 13:33:22 CST 2023, time=2023-03-09, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2206064, encodeId=0e7c2206064f1, content=偏重的研究方向：肝脏疾病;肿瘤 经验分享：现在pending的时间是变长了吗，看到23年的基本都是隔天送审，我已经pending4天了慌张。。。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74479171808, createdName=ms4000001066891631, createdTime=Wed May 22 18:36:10 CST 2024, time=2024-05-22, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2211109, encodeId=890422111096d, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：综合期刊;生命科学;医学综合 经验分享：2023年度影响因子为4.9分，还是相当不错的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/Random/55971dc507c93968175ce7cc1e177b372a83869f.jpg, createdBy=f63e4754896, createdName=侠胆医心, createdTime=Sat Jun 22 05:58:26 CST 2024, time=2024-06-22, status=1, ipAttribution=威斯康星), GetPortalCommentsPageByObjectIdResponse(id=2205292, encodeId=34342205292a0, content=请问免疫荧光的图也要未裁剪前的当原始数据吗？还有WB原始数据只要有对应的膜就行了吗，不是一定要全膜，且还要三次重复吧？IHC的图需要全片扫描的吗，还是特定展示区域的图就行？毕业在即，恳求解惑呀，各位大佬。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=89068352819, createdName=ms7000001215694189, createdTime=Fri May 17 21:53:58 CST 2024, time=2024-05-17, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2201848, encodeId=b39422018487d, content=偏重的研究方向：分子生物 经验分享：2023.12.20 22:00 Pending review 2023.12.21 16:00 Under review 2024.1.5 12:30 Pending major revise 2024.1.10 11:30 Resubmitted 2024.1.10 12:00 Requirements satisfied 2024.1.10 14:00 Pending review 2024.1.10 14:00 Revised version review 2024.1.11 16:00 Pending decision 2024.1.11 16:00 Pending editor decision 2024.1.13 15:00 Paper accepted 2024.1.13 15:00 Pending English 2024.1.14 English correction done 2024.1.14 16:30 Author poofreading 2024.1.14 22:30 Author poofreading-resubmitted 2024.1.15 13:00 Final check 2024.1.15 13:00 Pending conversation 2024.1.17 17:00 xml2pdf done 2023.1.17 17:30 pending online-website online, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7bb81967620, createdName=于陌上, createdTime=Sun May 05 17:17:49 CST 2024, time=2024-05-05, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2198932, encodeId=4a532198932bc, content=3天了没反应, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=125, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d40e6504141, createdName=ms8000002033126213, createdTime=Wed Apr 17 11:27:52 CST 2024, time=2024-04-17, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2197816, encodeId=3b6f219e816e6, content=同医院秒拒没给原因, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8a8a9166627, createdName=ms6000002076658983, createdTime=Wed Apr 10 20:43:04 CST 2024, time=2024-04-10, status=1, ipAttribution=北京)]

2024-04-10 ms6000002076658983 来自北京

同医院秒拒没给原因

105 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务